June 2, 2020 Report Open Access

Watson, James A; Meral, Rasimcan; Price, Richard; Simpson, Julie on behalf of 174 signatories

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Watson, James A</dc:creator>
  <dc:creator>Meral, Rasimcan</dc:creator>
  <dc:creator>Price, Richard</dc:creator>
  <dc:creator>Simpson, Julie on behalf of 174 signatories</dc:creator>
  <dc:date>2020-06-02</dc:date>
  <dc:description>Open letter to Mandeep R. Mehra, Sapan S. Desai, SreyRam Kuy, Timothy D. Henry, and Amit N. Patel, authors of “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19”. NEJM. 2020 May 1  DOI: 10.1056/NEJMoa2007621

 

and to Eric J Rubin (Editor-in-Chief of the New England Journal of Medicine and NEJM Group).</dc:description>
  <dc:identifier>https://zenodo.org/record/3873178</dc:identifier>
  <dc:identifier>10.5281/zenodo.3873178</dc:identifier>
  <dc:identifier>oai:zenodo.org:3873178</dc:identifier>
  <dc:relation>doi:10.5281/zenodo.3873177</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:subject>data integrity</dc:subject>
  <dc:subject>COVID-19</dc:subject>
  <dc:title>An open letter to Mehra et al and The New England Journal of Medicine</dc:title>
  <dc:type>info:eu-repo/semantics/report</dc:type>
  <dc:type>publication-report</dc:type>
</oai_dc:dc>